Skip to main content
. 2018 Sep 4;8(5):359–372. doi: 10.1159/000491763

Table 1.

Effects of DPP4i on biochemical examination results

Control group (n = 8) DPP4i group (n = 8) p
Fasting blood glucose, mg/dL 452&plusmn;75 366&plusmn;84 <0.05
HbA1c, % 6.1&plusmn;0.5 5.6&plusmn;0.6 <0.05
Fasting insulin, ng/mL 0.16&plusmn;0.04 0.17&plusmn;0.05 0.67
AST, IU/L 101&plusmn;26 77&plusmn;21 <0.05
ALT, IU/L 113&plusmn;32 92&plusmn;18 <0.05
Total cholesterol, mg/dL 158&plusmn;18 144&plusmn;20 0.34
Triglycerides, mg/dL 425&plusmn;124 310&plusmn;101 <0.05

Data are expressed as mean ± SD. Differences between the two groups were analyzed using the Wilcoxon rank-sum test.p values <0.05 were considered significant. DPP4i, dipeptidyl peptidase-4 inhibitor; HbA1c, hemoglobin A1c; AST, aspartate aminotransferase; ALT, alanine aminotransferase.